comparemela.com

Latest Breaking News On - Azithromycin - Page 1 : comparemela.com

Oral azithromycin reduces maternal sepsis and healthcare costs in low-resource settings

IPIAD augments standard therapy for pancreatic ductal adenocarcinoma

A new research perspective was published in Oncoscience (Volume 11) on February 7, 2024, entitled, "IPIAD- an augmentation regimen added to standard treatment of pancreatic ductal adenocarcinoma using already-marketed repurposed drugs irbesartan, pyrimethamine, itraconazole, azithromycin, and dapsone."

Azithromycin during routine well-infant visits does not reduce mortality

1. In this randomized controlled trial, infants who received a dose of azithromycin during their routine well visit had comparable mortality rates to placebo. 2. No differences were observed between the azithromycin and placebo groups with regard to rates of caregiver-reported hospitalization, sick-child clinic visits, or adverse events. Evidence Rating Level: 1 (Excellent) Study Rundown:

#VisualAbstract: Azithromycin during routine well-infant visits does not prevent death in Burkina Faso

Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.